Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Interaction among nitric oxide (NO)-related genes in migraine susceptibility (2012)

  • Authors:
  • USP affiliated authors: SPECIALI, JOSÉ GERALDO - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
  • USP Schools: FMRP; FMRP
  • DOI: 10.1007/s11010-012-1409-5
  • Subjects: ENXAQUECA (GENÉTICA); POLIMORFISMO; ÓXIDO NÍTRICO; ENDOTÉLIO VASCULAR
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s11010-012-1409-5 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Molecular and Cellular Biochemistry

    ISSN: 0300-8177

    Citescore - 2017: 2.71

    SJR - 2017: 1.003

    SNIP - 2017: 0.806


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP2350984pcd 2350984 estantes deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      GONÇALVES, Flavia M.; LUIZON, Marcelo R.; SPECIALI, Jose Geraldo; et al. Interaction among nitric oxide (NO)-related genes in migraine susceptibility. Molecular and Cellular Biochemistry, New York, v. 370, n. 1-2, p. 183-189, 2012. Disponível em: < http://dx.doi.org/10.1007/s11010-012-1409-5 > DOI: 10.1007/s11010-012-1409-5.
    • APA

      Gonçalves, F. M., Luizon, M. R., Speciali, J. G., Martins-Oliveira, A., Dach, F., & Tanus-Santos, J. E. (2012). Interaction among nitric oxide (NO)-related genes in migraine susceptibility. Molecular and Cellular Biochemistry, 370( 1-2), 183-189. doi:10.1007/s11010-012-1409-5
    • NLM

      Gonçalves FM, Luizon MR, Speciali JG, Martins-Oliveira A, Dach F, Tanus-Santos JE. Interaction among nitric oxide (NO)-related genes in migraine susceptibility [Internet]. Molecular and Cellular Biochemistry. 2012 ; 370( 1-2): 183-189.Available from: http://dx.doi.org/10.1007/s11010-012-1409-5
    • Vancouver

      Gonçalves FM, Luizon MR, Speciali JG, Martins-Oliveira A, Dach F, Tanus-Santos JE. Interaction among nitric oxide (NO)-related genes in migraine susceptibility [Internet]. Molecular and Cellular Biochemistry. 2012 ; 370( 1-2): 183-189.Available from: http://dx.doi.org/10.1007/s11010-012-1409-5

    Referências citadas na obra
    Maher BH, Griffiths LR (2011) Identification of molecular genetic factors that influence migraine. Mol Genet Genomics 285:433–446
    Victor T, Hu X, Campbell J, Buse D, Lipton R (2010) Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia 30:1065–1072
    Jensen R, Stovner LJ (2008) Epidemiology and comorbidity of headache. Lancet Neurol 7:354–361
    Martins-Oliveira A, Speciali JG, Dach F, Marcaccini AM, Gonçalves FM, Gerlach RF, Tanus-Santos JE (2009) Different circulating metalloproteinases profiles in women with migraine with and without aura. Clin Chim Acta 408:60–64
    Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR (2009) Neurobiology of migraine. Neuroscience 161:327–341
    Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, Lipton RB (2010) Migraine and cardiovascular disease: a population-based study. Neurology 74:628–635
    Kurth T, Chabriat H, Bousser MG (2012) Migraine and stroke: a complex association with clinical implications. Lancet Neurol 11:92–100
    Schurks M, Buring JE, Ridker PM, Chasman DI, Kurth T (2011) Genetic determinants of cardiovascular events among women with migraine: a genome-wide association study. PLoS ONE 6:e22106
    Olesen J (2010) Nitric oxide-related drug targets in headache. Neurotherapeutics 7:183–190
    Galletti F, Cupini LM, Corbelli I, Calabresi P, Sarchielli P (2009) Pathophysiological basis of migraine prophylaxis. Prog Neurobiol 89:176–192
    Pietrobon D, Striessnig J (2003) Neurological diseases: neurobiology of migraine. Nat Rev Neurosci 4:386–398
    Olesen J (2008) The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 120:157–171
    Sarchielli P, Floridi A, Mancini ML, Rossi C, Coppola F, Baldi A, Pini LA, Calabresi P (2006) NF-kappaB activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks. Cephalalgia 26:1071–1079
    Reuter U, Bolay H, Jansen-Olesen I, Chiarugi A, Sanchez del Rio M, Letourneau R, Theoharides TC, Waeber C, Moskowitz MA (2001) Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain 124:2490–2502
    Reuter U, Chiarugi A, Bolay H, Moskowitz MA (2002) Nuclear factor-kappaB as a molecular target for migraine therapy. Ann Neurol 51:507–516
    Scharfman HE, MacLusky NJ (2008) Estrogen growth factor interactions and their contributions to neurological disorders. headache. J Head Face Pain 48:S77–S89
    Facemire CS, Nixon AB, Griffiths R, Hurwitz H, Coffman TM (2009) Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression. Hypertension 54:652–658
    Goncalves FM, Martins-Oliveira A, Speciali JG, Izidoro-Toledo TC, Luizon MR, Dach F, Tanus-Santos JE (2010) Vascular endothelial growth factor genetic polymorphisms and haplotypes in women with migraine. DNA Cell Biol 29:357–362
    Gonçalves FM, Martins-Oliveira A, Speciali JG, Luizon MR, Izidoro-Toledo TC, Silva PS, Dach F, Tanus-Santos JE (2011) Endothelial nitric oxide synthase haplotypes associated with aura in patients with migraine. DNA Cell Biol 30:363–369
    MacClellan LR, Howard TD, Cole JW, Stine OC, Giles WH, O’Connell JR, Wozniak MA, Stern BJ, Mitchell BD, Kittner SJ (2009) Relation of candidate genes that encode for endothelial function to migraine and stroke: the stroke prevention in young women study. Stroke 40:e550–e557
    Mansur OS, Gonçalves FM T, Martins-Oliveira A, Speciali JG, Speciali JG, Dach F, Lacchini R, Tanus-Santos JE (2012) Inducible nitric oxide synthase haplotype associated with migraine and aura. Mol Cell Biochem 364:303–308
    Crawford DC, Nickerson DA (2005) Definition and clinical importance of haplotypes. Annu Rev Med 56:303–320
    Goncalves FM, Luizon MR, Speciali JG (2012) Haplotypes in candidate genes related to nitric oxide pathway and vascular permeability associated with migraine and aura. J Headache Pain 13:335–336
    Schürks M (2011) Genetics of migraine in the age of genome-wide association studies. J Headache Pain 13:1–9
    Schürks M, Kurth T, Buring JE, Zee RYL (2009) A candidate gene association study of 77 polymorphisms in migraine. J Pain 10:759–766
    Moore JH (2003) The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 56:73–82
    Moore JH (2004) Computational analysis of gene–gene interactions using multifactor dimensionality reduction. Expert Rev Mol Diagn 4:795–803
    Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69:138–147
    Motsinger AA, Brassat D, Caillier SJ, Erlich HA, Walker K, Steiner LL, Barcellos LF, Pericak-Vance MA, Schmidt S, Gregory S, Hauser SL, Haines JL, Oksenberg JR, Ritchie MD (2007) Complex gene–gene interactions in multiple sclerosis: a multifactorial approach reveals associations with inflammatory genes. Neurogenetics 8:11–20
    Corominas R, Sobrido MJ, Ribasés M, Cuenca-León E, Blanco-Arias P, Narberhaus B, Roig M, Leira R, López-González J, Macaya A, Cormand B (2009) Association study of the serotoninergic system in migraine in the Spanish population. Am J Med Genet B Neuropsychiatr Genet 153:177–184
    Joshi G, Pradhan S, Mittal B (2010) Role of the oestrogen receptor (ESR1 PvuII and ESR1 325 C→G) and progesterone receptor (PROGINS) polymorphisms in genetic susceptibility to migraine in a North Indian population. Cephalalgia 30:311–320
    Joshi G, Pradhan S, Mittal B (2011) Vascular gene polymorphisms (EDNRA −231 G>A andAPOEHhaI) and risk for migraine. DNA Cell Biol 30:577–584
    Lemos C, Mendonca D, Pereira-Monteiro J, Barros J, Sequeiros J, Alonso I, Sousa A (2010) BDNF and CGRP interaction: implications in migraine susceptibility. Cephalalgia 30:1375–1382
    Oterino A, Toriello M, Cayón A, Castillo J, Colas R, Alonson-Arranz A, Ruiz-Alegria C, Quintela E, Monton F, Ruiz-Lavilla N, Gonzalez F, Pascual J (2008) Multilocus analyses reveal involvement of the ESR1, ESR2, and FSHR genes in migraine. headache. J Head Face Pain 48:1438–1450
    Schürks M, Zee RYL, Buring JE, Kurth T (2009) Polymorphisms in the renin-angiotensin system and migraine in women. headache. J Head Face Pain 49:292–299
    SotIH Society HC (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9–160
    Sandrim VC, Palei AC, Cavalli RC, Araujo FM, Ramos ES, Duarte G, Tanus-Santos JE (2009) Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension. Mol Hum Reprod 15:115–120
    Luizon MR, Izidoro-Toledo TC, Simoes AL, Tanus-Santos JE (2009) Endothelial nitric oxide synthase polymorphisms and haplotypes in Amerindians. DNA Cell Biol 28:329–334
    Pattin KA, White BC, Barney N, Gui J, Nelson HH, Kelsey KT, Andrew AS, Karagas MR, Moore JH (2009) A computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reduction. Genet Epidemiol 33:87–94
    Wang SS (2006) Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis 27:1828–1834
    Olesen J, Thomsen LL, Iversen H (1994) Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 15:149–153
    Lassen LH, Ashina M, Christiansen I, Ulrich V, Olesen J (1997) Nitric oxide synthase inhibition in migraine. Lancet 349:401–402
    Hoffmann J, Goadsby PJ (2011) New agents for acute treatment of migraine: CGRP receptor antagonists, iNOS inhibitors. Curr Treat Options Neurol 14:50–59